[ad_1]
After it was rumored to be in play earlier this month, it shouldn’t come as an enormous shock that One Medical has discovered a brand new residence. After a torrid public providing, the worth of the American shopper healthcare and know-how firm had fallen under its IPO value, and it was an apparent goal for the correct purchaser.
However after CVS left the desk, it wasn’t a healthcare entity that snapped up the previous enterprise darling, and nor was it changed into a platform play by personal fairness. As a substitute, Amazon nabbed it up in a deal that involves round $3.9 billion. At $18 per share, One Medical is exiting the general public markets with a price ticket that’s greater than when it IPO’d — a win of kinds for the unprofitable firm.
What ought to we make of the Amazon deal, although? We coated the information on TechCrunch, and TechCrunch+ dug round into what the smaller firm may supply its new mother or father, so we’ve gathered to share just a few extra ideas on the matter.
From Walter Thompson, Miranda Halpern and Alex Wilhelm, three views comply with on the Amazon-One Medial transaction.
Walter Thompson: Amazon is the black gap created by the dying of Important Avenue retail
One Medical’s CEO stated his firm’s acquisition by Amazon is “a chance to rework well being care and enhance outcomes.” However I interpreted the pending $3.9 billion buy as a shiny, blinking signal that the world’s largest retailer just isn’t afraid of regulatory oversight or intervention. Amazon has moved past income era: At this level, the corporate largely exists to accrete extra mass.
[ad_2]